No more tubes? swallowable capsule could revolutionize stomach acid testing

NCT ID NCT00702533

First seen Jun 27, 2026 · Last updated Aug 05, 2026 · Updated 12 times

Summary

This study tests a new, less invasive way to measure stomach acid using a small wireless capsule (SmartPill) that patients swallow. It compares the capsule's accuracy to the standard method, which involves a tube placed through the nose into the stomach. The study includes healthy volunteers and people with acid-related disorders like Zollinger-Ellison syndrome and GERD.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
SmartPill (wireless capsule) and Pentagastrin injection
What this could lead to
If successful, this could replace the uncomfortable nasogastric tube test for measuring stomach acid, making diagnosis simpler and more tolerable for patients.
What could go wrong
This is an early-stage study with only 80 participants. The capsule may not be as accurate as the standard method, and results may not apply to all acid-related conditions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTRIC ACID SECRETORY DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • National Institutes of Health Clinical Center

    Bethesda, Maryland, 20892, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.